Who owns Tenpoint Therapeutics?

Tenpoint Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2022.

When did Sofinnova Partners acquire Tenpoint Therapeutics?

Sofinnova Partners acquired Tenpoint Therapeutics in 2022 (active for 4 years).

Home/Companies/Biotech/Tenpoint Therapeutics

Tenpoint Therapeutics

Biotech·

US·Active·4yr hold

Tenpoint Therapeutics is a healthcare company, headquartered in France.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Most recent investor

Sofinnova Partners

2 ownership periods

Key facts

HQFrance

SectorHealthcare

US biotech developing engineered cell-based therapies and in vivo reprogramming approaches to restore vision in ocular disease.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings